An interventional study of Early cranioplasty and Standard-of-care cranioplasty in Craniocerebral Trauma, Stroke and Intracranial Hemorrhages, sponsored by Thomas Jefferson University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Thomas Jefferson University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 95 studies in Craniocerebral Trauma with a site in United States — 12 open to participants now, 17 under way, none of them phase 3. Craniocerebral Trauma · United States.
Among the 95 studies in Craniocerebral Trauma with a site in United States, this one is the 43rd largest by planned enrollment of the 61 interventional ones that give a count, is one of 9 that started in 2024, is one of 50 with no phase, reaches primary completion later than 8 of the 16 other live ones, and was the 88th registered.
253 studies on the registry are indexed under Craniocerebral Trauma; 45 are open to participants now.
Browse Craniocerebral Trauma studies →12 of the 95 studies in Craniocerebral Trauma with a site in United States are open now. Recruiting first, the newest first:
Northern California Institute of Research and Education · Sites in United States
Ages 50–89
Wake Forest University Health Sciences · Sites in United States
Ages up to 18
New York Institute of Technology · Sites in United States
Ages 18–50 · Healthy volunteers
University of California, Davis · Sites in United States
Ages 11–17
VA Office of Research and Development · Sites in United States
Ages 22–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 25 Craniocerebral Trauma studies recruiting now, 8 (32%) set no upper age limit and 14 (56%) stop at 75 or younger; 8 take children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
95 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 4 · Phase 3 4 · Phase 4 2
First in 1983; this study’s year is marked. 9 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is below the median of 87 across 133 interventional studies indexed under Craniocerebral Trauma.
Median enrollment 94 across the 61 interventional studies, 192 across the 33 observational. Of the 69 that completed or were terminated, 17 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 95 have an industry lead sponsor. The 10 most frequent:
Thomas Jefferson University is the lead sponsor of 394 studies on the registry; 69 are open to participants now.
Of its 45 completed or terminated interventional studies of FDA-regulated products, 21 (47%) have results posted.
Thomas Jefferson University has 1 study filed under Craniocerebral Trauma — fewer than ten, so there is no comparison to draw.
3 of the studies in Craniocerebral Trauma with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06632587Thomas Jefferson UniversityTiming Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes | 2026-12-01 |
| NCT06697808Wake Forest University Health SciencesCranial Ultrasound for Point of Care Intracranial Pathology Detection in Pediatrics | 2027-04 |
| NCT05663034Johns Hopkins UniversityCBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms | 2027-06 |
Add all 3 to your calendar (.ics) → With an account.
Among the 95 studies in Craniocerebral Trauma with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).
This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).
The primary endpoint involves a comprehensive evaluation of long-term functional outcomes at 6 months post-injury ("injury" defined as "acute traumatic injury or source of increased intracranial pressure secondary to stroke or intracranial hemorrhage"). This assessment aims to determine whether the timing of cranioplasty influences patients' neurological recovery, cognitive function, and overall quality of life. By comparing the outcomes of patients who undergo standard of care cranioplasty with those who undergo early cranioplasty, the study seeks to provide valuable insights into the potential benefits of the latter approach.
The findings of this research hold the potential to guide clinical practice and inform decision-making for patients who have undergone DHC. By considering a range of complications and incorporating a robust statistical framework, the study contributes to a more nuanced understanding of the advantages and disadvantages associated with different cranioplasty timing strategies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cranioplasty procedure performed prior to 8 weeks following the initial decompressive hemicraniectomy.
Procedure: Early cranioplasty
Cranioplasty procedure performed after 3 months following the initial decompressive hemicraniectomy.
Procedure: Standard-of-care cranioplasty
Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Early cranioplasty is defined as being performed within 8 weeks following the decompressive hemicraniectomy.
Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Standard-of-care cranioplasty is defined as being performed after 3 months following the decompressive hemicraniectomy.
Functional outcome at 6 months post-decompressive hemicraniectomy
modified Rankin scale outcome at 6 months post-decompressive hemicraniectomy
Time frame: 6 months post-decompressive hemicraniectomy
Functional outcome at 12 months post-decompressive hemicraniectomy
modified Rankin scale outcome at 12 months post-decompressive hemicraniectomy
Time frame: 12 months post-decompressive hemicraniectomy
Post-cranioplasty seizure
Post-cranioplasty seizure occurrence, diagnosed clinically or on EEG
Time frame: 1 month post-cranioplasty
Post-cranioplasty hydrocephalus
Post-cranioplasty hydrocephalus or need for cerebrospinal fluid diversion
Time frame: 1 month post-cranioplasty
Post-cranioplasty return to operating room
All-cause return to operating room after cranioplasty
Time frame: 1 month post-cranioplasty
Post-cranioplasty infection
Surgical site or intracranial infection after cranioplasty
Time frame: 12 months post-cranioplasty
Post-cranioplasty disposition
Post-cranioplasty disposition (home, acute rehab, subacute rehab, death)
Time frame: 12 months post-cranioplasty
Post-cranioplasty length of hospital stay
Post-cranioplasty length of hospital stay
Time frame: 12 months post-cranioplasty
Readmission within 30 days post-cranioplasty
Readmission within 30 days post-cranioplasty
Time frame: 30 days post-cranioplasty
Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 26 months after the start.
Of 50 non-industry interventional studies with no phase under Craniocerebral Trauma, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 61. This study's planned 26 months is close to that.
Counting every sponsor, half of 51 studies reached it within 26 months; a quarter within 11 and three quarters within 61.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Sep 2027 → Dec 2026 and completion Sep 2027 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.